IP Library Granted Patent US 7,572,597
Granted Patent B2
US 7,572,597 · App. 10/520,084 · Granted Aug 11, 2009

Diagnostics method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,572,597
App. No.
10/520,084
Granted
Aug 11, 2009
Kind
B2
Abstract

Method of diagnosing in an individual recent exposure to an agent which is a pathogen, vaccine or any other moiety which induces a cellular response, said method comprising determining in vitro whether the T cells of the individual recognise a protein from said agent having a length of at least 30 amino acids, to a greater extent than one or more peptide epitopes from the agent, a greater extent of recognition of the protein indicating that the individual has recently been exposed to the agent.

Claims (44)

1. A method of diagnosing in an individual a recent exposure to M. tuberculosis , said method comprising:

(a) providing a T cell-containing sample from said individual;

(b) contacting different aliquots of said sample separately with antigen compositions comprising either whole ESAT-6, or peptide epitopes derived from ESAT-6 that are 8 to 29 amino acids in length, in ELISPOT assays in order to determine the frequency of antigen-responsive T cells which have been induced to secrete a cytokine; and

(c) evaluating the responsive T cells in each separate ELISPOT assay, wherein a positive response using whole ESAT-6 and a negative response using said peptide epitopes indicates that the individual has recently been exposed to M. tuberculosis.

2. A method according to claim 1 , wherein said peptide epitopes are 12 to 25 amino acids in length.

3. A method according to claim 1 , wherein a pool of at least four different peptide epitopes is employed.

4. A method according to claim 1 , wherein said peptide epitopes represent all possible peptide epitopes derived from ESAT-6.

5. A method according to claim 1 , wherein antigen presenting cells are present in said sample.

6. A method according to claim 1 , wherein said peptide epitopes are selected from the group consisting of:

MTEQQWNFAGIEAAA,

(SEQ ID NO:1)

WNFAGIEAAASAIQG,

(SEQ ID NO:2)

IEAAASAIQGNVTSI,

(SEQ ID NO:3)

SAIQGNVTSIHSLLD,

(SEQ ID NO:4)

NVTSIHSLLDEGKQS,

(SEQ ID NO:5)

HSLLDEGKQSLTKLA,

(SEQ ID NO:6)

EGKQSLTKLAAAWGG,

(SEQ ID NO:7)

LTKLAAAWGGSGSEA,

(SEQ ID NO:8)

AAWGGSGSEAYQGVQ,

(SEQ ID NO:9)

SGSEAYQGVQQKWDA,

(SEQ ID NO:10)

YQGVQQKWDATATEL,

(SEQ ID NO:11)

QKWDATATELNNALQ,

(SEQ ID NO:12)

TATELNNALQNLART,

(SEQ ID NO:13)

NNALQNLARTISEAG,

(SEQ ID NO:14)

NLARTISEAGQAMAS,

(SEQ ID NO:15)

ISEAGQAMASTEGNV,

(SEQ ID NO:16)

and

QAMASTEGNVTGMFA.

(SEQ ID NO:17)

Assignments (8)
RELEASE OF SECURITY INTEREST (TERM) Recorded Nov 7, 2018
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: OXFORD IMMUNOTEC, INC.; OXFORD IMMUNOTEC GLOBAL PLC; OXFORD IMMUNOTEC LIMITED; IMMUNETICS, INC.
Reel/Frame 047445/0487 →
RELEASE OF SECURITY INTEREST (REVOLVING) Recorded Nov 7, 2018
From: MIDCAP FUNDING IV TRUST, AS SUCCESSOR TO MIDCAP FINANCIAL TRUST
To: OXFORD IMMUNOTEC, INC.; OXFORD IMMUNOTEC GLOBAL PLC; OXFORD IMMUNOTEC LIMITED; IMMUNETICS, INC.
Reel/Frame 047890/0001 →
SECURITY INTEREST (REVOLVING LOAN) Recorded Oct 5, 2016
From: OXFORD IMMUNOTEC, INC.; OXFORD IMMUNOTEC GLOBAL PLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 040227/0257 →
SECURITY INTEREST (TERM LOAN) Recorded Oct 5, 2016
From: OXFORD IMMUNOTEC, INC.; OXFORD IMMUNOTEC GLOBAL PLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 040228/0887 →
CHANGE OF NAME Recorded Aug 2, 2016
From: ISIS INNOVATION LIMITED
To: OXFORD UNIVERSITY INNOVATION LIMITED
Reel/Frame 039550/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2014
From: ISIS INNOVATION LIMITED
To: OXFORD IMMUNOTEC LIMITED
Reel/Frame 032945/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2014
From: ISIS INNOVATION LIMITED
To: OXFORD IMMUNOTEC LIMITED
Reel/Frame 032191/0698 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2005
From: LALVANI, AJIT; EWER, KATIE
To: ISIS INNOVATION LIMITED
Reel/Frame 016541/0892 →